510(k) · Cleared
ClearedUltimate rTMS; Yingchi rTMS
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Brain Ultimate, Inc. · OBP Transcranial Magnetic Stimulator
Cleared on Sep 13, 2023 as substantially equivalent to K171481 (Tonica Elektronik A/S, 2017) and 1 other predicate after a 181-day review. Its family tree reaches back 6 generations to 2008. 1 later device descends from it.
- Decided
- Sep 13, 2023
- Review
- 181 days
- Class
- Class II
- Product code
- OBP
- Recalls
- None
- Predicates
- 2
Its longest line of descent runs back 6 generations to DEN070003 (2008). 8 ancestors in all. 1 later device descends from it, 1 citing it directly.
- Root · 6 generations backDEN070003 Neurostar TMS SystemNeuronetics · 2008
- 5 generations backK083538 Neurostar TMS Therapy System, Model 1.1Neuronetics · 2008 · Recalled
- 4 generations backK130233 Neurostar TMS Therapy SystemNeuronetics · 2013
- 3 generations backK133408 Neurostar TMS Therapy SystemNeuronetics · 2014
- 2 generations backK150641 MagVita TMS Therapy SystemTonica Elektronik A/S · 2015
- 1 generation backK171481 MagVita TMS Therapy SystemTonica Elektronik A/S · 2017
- This deviceK230735 Ultimate rTMS; Yingchi rTMSBrain Ultimate, Inc. · 2023
- Descendant · cites it directly · 0 of its ownK260396 KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim…Fidelity BioPharma Co. · 2026
Most influential descendants
Showing 1 of 1 · See all- K260396KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A)Fidelity BioPharma Co. · 2026 · cites it directly0descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | DEN070003 | Neurostar TMS System | Neuronetics | 2008 | — |
| −5 | K083538 | Neurostar TMS Therapy System, Model 1.1 | Neuronetics | 2008 | 1 |
| −4 | K130233 | Neurostar TMS Therapy System | Neuronetics | 2013 | — |
| −3 | K133408 | Neurostar TMS Therapy System | Neuronetics | 2014 | — |
| −2 | K150641 | MagVita TMS Therapy System | Tonica Elektronik A/S | 2015 | — |
| −1 | K171481 | MagVita TMS Therapy System | Tonica Elektronik A/S | 2017 | — |
| 0 (this device) | K230735 | Ultimate rTMS; Yingchi rTMS | Brain Ultimate, Inc. | 2023 | — |
| +1 | K260396 | KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100… | Fidelity BioPharma Co. | 2026 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2015 | 1 | 0 |
| 2016 | 1 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in OBP? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new OBP device
- #1 K251119 MagVenture TMS Therapy Systemscore 21.8 · 11 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (2)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K171481 | MagVita TMS Therapy SystemSummary page 4…Stimulator Device Class: Class II Product Code: OBP 3. PREDICATE DEVICES Tonica Electronik A/S, MagVita TMS Therapy System, K171481 Magstim Company Limited, Rapid2 Therapy System, K143531 4. DEVICE DESCRIPTION Transcranial Magnetic Stimulation (TMS)… | 2017 |
| * | K143531 | Rapid Therapy SystemSummary page 4…ode: OBP 3. PREDICATE DEVICES Tonica Electronik A/S, MagVita TMS Therapy System, K171481 Magstim Company Limited, Rapid2 Therapy System, K143531 4. DEVICE DESCRIPTION Transcranial Magnetic Stimulation (TMS) is a painless and non‐invasive neuromodulation technique. It dir… | 2015 |
What descends from it? (1)
1 later device cites it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K260396 | KCS rTMS Therapy System (Transcranial Magnetic Stimulator) (MetaStim 100, MetaStim 100A) | 2026 | 0 |
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 15 years and passes through 3 companies; a new generation was cleared every 1.9 years on median.
- 2 of the 8 ancestors have a recall of any class.
- Of its descendants, K260396 (Fidelity BioPharma Co., 2026) has gone furthest, with 0 descendants of its own.
- 6 other devices also cite its predicate K171481.
How does its category compare?
All OBP devicesOBP Transcranial Magnetic Stimulator: FDA decisions, review times, recalls and adverse event reports over 20 years. 2023, this device’s year, is highlighted.
FDA decisions per year · OBP
12in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · OBP
125in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · OBP
1in 2018
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · OBP
81in 2025
MAUDE reports naming product code OBP, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 0 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 0 |
| 2009 | 0 | — | 1 | 3 |
| 2010 | 0 | — | 0 | 0 |
| 2011 | 0 | — | 0 | 5 |
| 2012 | 0 | — | 0 | 3 |
| 2013 | 2 | — | 0 | 1 |
| 2014 | 1 | — | 0 | 0 |
| 2015 | 2 | — | 0 | 3 |
| 2016 | 3 | 101 | 0 | 6 |
| 2017 | 8 | 73 | 0 | 3 |
| 2018 | 4 | 144 | 1 | 6 |
| 2019 | 3 | 156 | 0 | 12 |
| 2020 | 1 | — | 0 | 12 |
| 2021 | 5 | 132 | 0 | 15 |
| 2022 | 6 | 168 | 0 | 59 |
| 2023 | 7 | 119 | 0 | 43 |
| 2024 | 5 | 266 | 0 | 50 |
| 2025 | 12 | 125 | 0 | 81 |
| 2026 | 8 | 176 | 1 | — |
What is it indicated for?
The Ultimate rTMS is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K230735 · printed Nov 6, 2026
Cite this page
510(k) Report. “K230735: Ultimate rTMS; Yingchi rTMS.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K230735
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026